comScore
Active Stocks
Fri Sep 29 2023 15:59:14
  1. Tata Steel share price
  2. 129 1.78%
  1. NTPC share price
  2. 245.65 3.3%
  1. Power Grid Corporation Of India share price
  2. 199.85 -0.45%
  1. State Bank Of India share price
  2. 598.7 1.48%
  1. Wipro share price
  2. 406.25 0.11%
Business News/ News / Govt bans 14 fixed dose combination drugs including Nimesulide and Paracetamol, citing health risk; check full list here
Back

Govt bans 14 fixed dose combination drugs including Nimesulide and Paracetamol, citing health risk; check full list here

Centre has banned 14 FDC drugs due to ‘no therapeutic justification’ and potential risk to patients, including Nimesulide and Paracetamol dispersible tablets and Chlopheniramine Maleate and Codeine syrup. The Health Ministry issued the notification based on recommendations from an expert committee.

The Health Ministry issued a notification in this regard.Premium
The Health Ministry issued a notification in this regard.

The Centre has banned 14 fixed dose combination (FDC) drugs in the country saying that there is "no therapeutic justification" for these medicines and they may involve "risk" to people. FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio. The move came following recommendations by an expert committee. The Health Ministry has also issued a notification on this regard.

These 14 fixed dose combination drugs including Nimesulide and Paracetamol dispersible tablets and Chlopheniramine Maleate and Codeine syrup. FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio.

These banned drugs included those used for treating common infections, cough and fever combinations such as: Nimesulide Paracetamol dispersible tablets, Chlopheniramine Maleate Codeine Syrup, Pholcodine Promethazine, Amoxicillin Bromhexine and Bromhexine Dextromethorphan Ammonium Chloride Menthol, Paracetamol Bromhexine Phenylephrine Chlorpheniramine Guaiphenesin and Salbutamol Bromhexine. 

The expert committee said that there is "no therapeutic justification for this FDC (fixed dose combination) and the FDC may involve risk to human beings. Hence, in the larger public interest, it is necessary to prohibit the manufacture, sale or distribution of this FDC under section 26 A of the Drugs and Cosmetics Act, 1940. In view of the above, any kind of regulation or restriction to allow for any use in patients is not justifiable."

As per the notification issued by the Health Ministry, "And whereas, on the basis of the recommendations of the Expert Committee and the Drugs Technical Advisory Board, the Central Government is satisfied that it is necessary and expedient in public interest to regulate by way of prohibition the manufacture for sale, sale and distribution for human use of the said drug in the country," the notification stated.

Earlier in 2016, the government had announced the ban on the manufacture, sale and distribution of 344 drug combinations after an expert panel, set up at the behest of the Supreme Court had stated they were being sold to patients without scientific data and the order was challenged by the manufacturers in court. The current banned 14 FDCs are also part of those 344 drug combinations.

(With inputs from PTI)

"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Updated: 04 Jun 2023, 07:04 AM IST
Next Story
Recommended For You
Switch to the Mint app for fast and personalized news - Get App